Home
Profiles
Research Units
Research Outputs
SDG
Collaborations
EN
Main menu
Back to Projects
Diğer (Uluslararası)
Devam Ediyor
ULUSLARARASI
MK7684A Protocol 003: MK-7684 with Pembrolizumab as a Coformulation (MK-7684A) Versus Pembrolizumab Monotherapy for PD-L1 Positive Metastatic NSCLC.
Project details
Funding institution
Diğer (Uluslararası)
Duration
16.06.2021
Unit
Faculty of Medicine • Department of Internal Medicine
Project team
DİLEK ERDEM
